Skip to main content
Equibles
DH logo

DH · Definitive Healthcare Corp.

Track DH — free

Use DH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.05 +0.01 (+0.96%) At close · Sep 4
Rebalance outlook locked
Market Cap
$112.08M
Shares
106.74M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.05 Open$1.02 Day$1.02–1.05 52W close$0.63–4.30 Avg vol 30d565K Short int2.1M · 1.9% float · 8.5d Short vol9% Last earningsAug 10, 2026 DataSep 2021–Sep 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 9 wks
Latest filing: 10-Q
filed Aug 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$232.70M
Trailing 12 months
Net income (TTM)
−$120.33M
Trailing 12 months
Revenue growth YoY
-9.1%
Year over year
Operating margin
-104.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
25.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$22.96M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.9%
Year over year · fewer shares
Price change (1Y)
-73.8%
Trailing year
Short interest
1.9%
Latest settlement · 8.5 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −24%
below
Price vs 50-day avg +38%
above
RSI (14) 76
overbought
MACD trend Positive
52-week position 11%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +47%
trailing
6-month return −5%
trailing
YTD return −63%
this year
Relative strength −20%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-16% holders QoQ · +18 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.93% of float · ▲ +4.7% MoM · 8.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
100 holders — near 3-yr low, contrarian setup
Squeeze score 80
high risk · 0–100
Fundamentals
Strong
Revenue growth −4%
Y/Y
Gross margin 76%
contracting
EPS growth +63%
Y/Y
Free cash flow $37.1M
Buyback $120.0M
authorized
Balance sheet $1.2M
net debt
Quant / Vol
risk profile
Very High
Volatility 77%
annualized · 1-yr
Max drawdown −85%
past year
ATR 7.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 2
Latest guidance · from the 8-K filed Aug 10, 2026
Third Quarter 2026
Revenue Initiated $54M – $55M
prior qtr $55.2M midpoint −1.3% QoQ
Adjusted Operating Income Non-GAAP Initiated $10.5M – $11.5M
Adjusted EBITDA Margin Non-GAAP Initiated 25% – 27%
Adjusted EBITDA Non-GAAP Initiated $13.5M – $14.5M
Adjusted Net Income Per Diluted Share Non-GAAP Initiated $0.04 – $0.05
Adjusted Net Income Non-GAAP Initiated $5.5M – $6.5M
Full Year 2026
Revenue Initiated $220M – $222M
prior FY $241.52M midpoint −8.5% Y/Y
Adjusted Operating Income Non-GAAP Initiated $45.5M – $47.5M
Adjusted EBITDA Non-GAAP Initiated $57M – $59M
Adjusted Net Income Per Diluted Share Non-GAAP Initiated $0.18 – $0.20
Prior guidance period ended · from the Earnings Call filed Nov 8, 2021
Total revenue · Q4 $44M – $45M
Non-GAAP income from operations · Q4 $11.5M – $12.5M
Earnings per diluted share · Q4 $0.04 – $0.05
Total revenue · full year 2021 $164M – $165M
Non-GAAP income from operations · full year 2021 $52M – $53M
Earnings per diluted share · full year 2021 $0.08 – $0.09
Adjusted EBITDA · full year 2021 $55M – $56M
Non-GAAP net income · full year 2021 $13M – $14M
Guided vs delivered · last 2 settled
Total revenue Q4
guided $44M – $45M
$46.31M Beat +4.1%
Total revenue full year 2021
guided $164M – $165M
$166.15M Beat +1.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−24% Bearish
Price vs 50-day avg
+38% Bullish
RSI (14)
76 Bearish
MACD trend
Positive Bullish
52-week position
11% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-16% holders QoQ · +18 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.93% of float · ▲ +4.7% MoM · 8.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
100 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $1 · 11% Range high $4
vs 200-day avg -24% vs 50-day avg +38%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DH
Definitive Healthcare Corp.
this stock
$112.08M -63.4% -4.2% — 1.9%
VEEV
Veeva Systems Inc
 $46.04B +23.2% +28.1% 46.5 3.6%
PMDIY
Pro Medicus Ltd./ADR
 $13.01B -25.0% — — 0.0%
BTSG
BrightSpring Health Services, Inc.
 $12.02B +62.2% +28.2% 36.8 4.5%
TEM
Tempus AI, Inc.
 $11.67B +9.4% +83.4% — 16.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
100
% held
81.2%
Net QoQ
-2.1M sh
Top holder
Advent International, L.P.
Held Float
View
Held by Funds
Fund positions
70
View
Short & Settlement
Short Interest Rising
Shares short
2.1M
Days to cover
8.5d
Change
+91.6K sh
View
Short Volume
Short vol %
9%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
3
Value
$2
As of
Jul 29, 2026
View
Off-Exchange
Off-exchange %
52.2%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$241.5M
Net income (FY)
$-138.9M
EPS diluted
$-1.30
View
Buybacks
Authorized · 2 programs
$120.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 2, 2026
This year
13
View
Proposed Sales
Value
$209.3K
Shares
45.0K
Filed
Dec 3, 2024
View
Earnings & Events
Earnings Calls
Last call
Aug 10, 2026
View

Performance

5D 20D 120D MTD YTD
DH +30.9% +47.1% -4.6% +10.5% -63.4%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +30.8% +47.5% -19.7% +10.1% -76.4%

Capital returns

Buyback programs · 2 active · as of Nov 1, 2024
Authorized (total)
$120.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1861795 CUSIP 24477E103 13F (30d) 79 filings 78 filers Visit website Investor relations